Latest News

eye on pharma banner
Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission

April 4th 2024

A Chinese company has expressed interest in developing a biosimilar to Ozempic (semaglutide); Celltrion completed its biologic license application for its omalizumab biosimilar candidate.

syringes | Image credit: SOPONE - stock.adobe.com
Analyzing Safety of Switching From Originators to Biosimilars: A Meta-Analysis of 21 Trials

February 10th 2024

AI generated image for cost savings | Image credit: 1st footage - stock.adobe.com
Report: Varied Biosimilar Uptake Speeds Pose Missed Opportunities for Cost Savings

January 23rd 2024

globe stethoscope medicine | Image credit: Planetz - stock.adobe.com
IQVIA Projects $192 Billion Loss for Originators by 2028 Thanks to Biosimilar, Generic Competition

January 18th 2024

syringe and needle | Image credit: Inna Dodor - stock.adobe.com
IQVIA Report Flags Challenges With Biosimilar Access, Savings Throughout Europe

January 10th 2024

Video Interviews
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.